SREBF1 and metabolic dysfunction-associated steatotic liver disease: In NAFLD livers, YTHDC2, which binds to stearoyl‐CoA desaturase 1 (SCD1), FASN, SREBP‐1c, ACC1, and reduces the stability of their mRNA and blocks gene expression, is markedly downregulated, leading to the accumulation of TGs and the progression of NAFLD.46